Concepedia

Publication | Open Access

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)

DOIFull Paper Access

91

Citations

26

References

2013

Year

Dick de Zeeuw, Tadao Akizawa, Rajiv Agarwal, Paul Audhya, George L. Bakris, Melanie Chin, Melissa Krauth, Hiddo J.L. Heerspink, Colin J. Meyer, John J.V. McMurray,
American Journal of Nephrology

Abstract

BEACON will be the first event-driven trial to evaluate the effect of an oral antioxidant and anti-inflammatory drug in advanced CKD.

References

YearCitations

Page 1